Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-PACT: Antithrombotic Therapy in Critically-Ill COVID-19 Patients
NCT04409834Phase 4Completed
- Sponsor
- TIMI Study Group
- Start
- Aug 2020
- Primary completion
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of heparin, enoxaparin, clopidogrel in venous thromboembolism (VTE), arterial thrombosis, sponsored by TIMI Study Group. Started Aug 2020; status: completed.
02
Drugs
heparinenoxaparinclopidogrel
03
Conditions
venous thromboembolism (VTE)arterial thrombosis
Beyond the preview
Go deeper on NCT04409834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04409834.